Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic
Abstract The coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 that has significant implications for the …
severe acute respiratory syndrome coronavirus 2 that has significant implications for the …
Stroke in China: advances and challenges in epidemiology, prevention, and management
With over 2 million new cases annually, stroke is associated with the highest disability-
adjusted life-years lost of any disease in China. The burden is expected to increase further …
adjusted life-years lost of any disease in China. The burden is expected to increase further …
Epidemiology of cardiovascular disease in China: current features and implications
D Zhao, J Liu, M Wang, X Zhang, M Zhou - Nature Reviews Cardiology, 2019 - nature.com
Cardiovascular disease (CVD) is the leading cause of death in China. To develop effective
and timely strategies to cope with the challenges of CVD epidemics, we need to understand …
and timely strategies to cope with the challenges of CVD epidemics, we need to understand …
Towards diagnostic aided systems in coronary artery disease detection: a comprehensive multiview survey of the state of the art
Introduction. Coronary artery disease (CAD) is one of the main causes of death all over the
world. One way to reduce the mortality rate from CAD is to predict its risk and take effective …
world. One way to reduce the mortality rate from CAD is to predict its risk and take effective …
Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China
Importance Dyslipidemia, the prevalence of which historically has been low in China, is
emerging as the second leading yet often unaddressed factor associated with the risk of …
emerging as the second leading yet often unaddressed factor associated with the risk of …
Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative …
Objective To examine the effect of the 2017 American College of Cardiology
(ACC)/American Heart Association (AHA) hypertension guidelines on the prevalence of …
(ACC)/American Heart Association (AHA) hypertension guidelines on the prevalence of …
Landscape of cardiometabolic risk factors in Chinese population: a narrative review
JJ Li, HH Liu, S Li - Cardiovascular diabetology, 2022 - Springer
With rapid economic growth and changes at all levels (including environmental, social,
individual), China is facing a cardiovascular disease (CVD) crisis. In China, more than 40 …
individual), China is facing a cardiovascular disease (CVD) crisis. In China, more than 40 …
[HTML][HTML] Stroke as a complication and prognostic factor of COVID-19
JMTG y Galán - Neurología (English Edition), 2020 - Elsevier
Introduction Contradictory data have been reported on the incidence of stroke in patients
with COVID-19 and the risk of SARS-CoV-2 infection among patients with history of stroke …
with COVID-19 and the risk of SARS-CoV-2 infection among patients with history of stroke …
Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores
CJ Nicholson, L Wooster, HH Sigurslid, RH Li… - …, 2021 - thelancet.com
Background Risk stratification of COVID-19 patients upon hospital admission is key for their
successful treatment and efficient utilization of hospital resources. We sought to evaluate the …
successful treatment and efficient utilization of hospital resources. We sought to evaluate the …
Prevalence of dyslipidemia and associated risk factors among adults aged≥ 35 years in northern China: a cross-sectional study
Y Xi, L Niu, N Cao, H Bao, X Xu, H Zhu, T Yan… - BMC Public Health, 2020 - Springer
Background Cardiovascular disease (CVD) prevalence has increased continuously over the
last 30 years in China. Dyslipidemia is an important modifiable risk factor in CVD. We aimed …
last 30 years in China. Dyslipidemia is an important modifiable risk factor in CVD. We aimed …